Dolby Laboratories Inc/ US25659T1079 /
30/12/2024 18:54:24 | Chg. -0.26 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
78.22USD | -0.33% | 3,013 Turnover: 233,818.08 |
-Bid Size: - | -Ask Size: - | 7.46 bill.USD | 1.54% | 28.53 |
Assets
|
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
2024 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 541.9630 | 534.3810 | 513.4810 | 481.5810 | 479.1090 | ||||||
Intangible Assets | 152.4310 | 122.8900 | 112.2650 | 167.4270 | 434.5140 | ||||||
Long-Term Investments | 52.1490 | 62.8190 | 102.5140 | 97.8120 | 89.2670 | ||||||
Fixed Assets | 1,370.1290 | 1,345.1890 | 1,378.6540 | 1,491.9620 | 1,915.5110 | ||||||
Inventories | 25.5500 | 10.9650 | 23.5490 | 35.6230 | 33.7280 | ||||||
Accounts Receivable | 180.3400 | 232.6090 | 243.5930 | 262.2450 | 315.4650 | ||||||
Cash and Cash Equivalents | 1,071.8760 | 1,225.3800 | 620.1270 | 745.3640 | 482.0470 | ||||||
Current Assets | 1,547.1960 | 1,760.4980 | 1,310.8940 | 1,487.8040 | 1,194.4170 | ||||||
Total Assets | 2,917.3250 | 3,105.6870 | 2,689.5480 | 2,979.7660 | 3,109.9280 |
Liabilities
|
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
2024 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 12.6170 | 17.7790 | 14.1710 | 20.9250 | 17.3800 | ||||||
Long-term debt | - | - | - | - | - | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | - | - | - | - | - | ||||||
Liabilities | 478.9200 | 501.4550 | 438.5280 | 607.5820 | 623.0350 | ||||||
Share Capital | .0580 | .0590 | .0530 | .0530 | .0530 | ||||||
Total Equity | 2,438.4050 | 2,604.2320 | 2,251.0200 | 2,372.1840 | 2,486.8930 | ||||||
Minority Interests | 5.7620 | 6.2530 | 4.8370 | 17.0840 | 9.7310 | ||||||
Total liabilities equity | 2,917.3250 | 3,105.6870 | 2,689.5480 | 2,979.7660 | 3,109.9280 |
Income Statement
|
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
2024 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1,161.7920 | 1,281.2560 | 1,253.7930 | 1,299.7440 | 1,273.7210 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 218.7420 | 344.3900 | 206.6050 | 215.7530 | 258.3260 | ||||||
Interest Income | 12.5390 | 3.0140 | 6.1740 | 28.0860 | 34.0770 | ||||||
Income Before Taxes | 239.7150 | 354.5120 | 215.2790 | 250.0530 | 312.4790 | ||||||
Income Taxes | -8.0960 | -36.6890 | -31.3810 | -48.4090 | -48.1630 | ||||||
Minority Interests Profit | -.2560 | -7.5960 | .1890 | -.9880 | -2.4910 | ||||||
Net Income | 231.3630 | 310.2270 | 184.0870 | 200.6560 | 261.8250 |
Per Share
Cash Flow
|
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
2024 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 343.8490 | 447.7530 | 318.5760 | 367.0810 | 327.2520 | ||||||
Cash Flow from Investing Activities | 134.3740 | -44.9050 | -295.9350 | 54.2060 | -286.2920 | ||||||
Cash Flow from Financing | -207.7750 | -252.5150 | -610.5580 | -236.8120 | -287.8140 | ||||||
Decrease / Increase in Cash | 274.3860 | 153.0530 | -604.6610 | 189.5950 | -240.2140 | ||||||
Employees | - | - | - | - | - |